Shiro Katayama
Direktor/Vorstandsmitglied bei Japan BCG Laboratory KK
Ursprung des Netzwerks ersten Grades von Shiro Katayama
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Japan BCG Laboratory KK
 Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan.
7
| Private Company | Biotechnology | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Shiro Katayama
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|
Statistik
International
Sektoral
Operativ
| Director/Board Member | 7 |
| President | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Shin Kaitani | 1 |
| Manabu Sugano | 1 |
| Naoki Nakata | 1 |
| Takahiko Ikegami | 1 |
| Jun Saito | 1 |
| Hoko Yamashita | 1 |
| Tsuguo Sasaki | 1 |
- Börse
- Insiders
- Shiro Katayama
- Unternehmensverbindungen
